跳至主要内容
临床试验/NCT05797779
NCT05797779招募中不适用

Molecular Characterization of Induced Neuronal Cells Derived From Fibroblasts of Patients With Parkinson's Disease

Fondazione Policlinico Universitario Agostino Gemelli IRCCS2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2021年3月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
45
试验地点
2
主要终点
Neurophysiological characterization of dopaminergic neurons derived from patients with Parkinson's disease.

研究概览

简要总结

To describe the molecular, electrophysiological and morphological expression profile of dopaminergic neurons derived from fibroblasts of patients with Parkinson's disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects aged 18 years or older
  • Patients with Parkinson's disease, according to the most recent diagnostic criteria
  • Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study

排除标准

  • Patients affected by drug-induced parkinsonism or atypical parkinsonian disorders
  • Patients with neurological diseases other than Parkinson's disease
  • Inability to sign an informed consent
  • Severe psychiatric diseases

结局指标

主要结局

Neurophysiological characterization of dopaminergic neurons derived from patients with Parkinson's disease.

时间窗: Baseline

To evaluate the firing frequency in the dopaminergic neurons derived from fibroblasts of patients with Parkinson's disease.

Biochemical characterization of dopaminergic neurons derived from patients with Parkinson's disease.

时间窗: Baseline

To determine the amount of dopamine released from differentiated neurons derived from fibroblasts of patients with Parkinson's disease.

α-synuclein misfolding in dopaminergic neurons derived from patients with Parkinson's disease.

时间窗: Baseline

To document the presence of abnormal accumulation of misfolded alpha-synuclein in the dopaminergic neurons derived from fibroblasts of patients with Parkinson's disease.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验